Measuring a structural parameter of the prostate — specifically, the prostatic urethral angle — is a potential predictor of the response of BPH patients’ to alpha blocker monotherapy to treat nocturia, a lower urinary tract symptom. Angles below 33.5 degrees are generally associated with improvements, researchers said.
